Senolytic Study 3

We are seeking 25 participants to partake in a study of a new healthy aging product we have developed. The product is formulated to help the body eliminate the stressed cells that accumulate with aging (i.e., senescent or zombie cells). 

The trial and data collection will run for approximately 1 month.

The product will be packaged in capsules, with a dosage of 6 capsules taken on supplementation days. There are 6 supplementation days during the study, with each cycle of two days of supplementation separated by 12 days with no supplementation.

All participants will be given enough capsules of the product for 6 doses (i.e., 3 boxes). Participants will be instructed to take the product for 2 consecutive days, cycle off for 12 days, then take for 2 more consecutive days, cycle off for 12 days, and then take for a final 2 consecutive days. Participants will also be instructed to take the product any time in the morning with or without food. 

Participants will be instructed to not begin taking any new supplements while testing this product and continue taking any supplements they are currently using regularly.

All participants will start at the same time on Saturday, November 4th.

Participation Requirements:

  1. Provided voluntary, written, informed consent to participate in the study
  2. Participants will be eligible to be included who answer yes to the questions in the baseline screening waiver.
  3. Male and female participants 35+ years of age.
  4. Willingness to complete questionnaires, records, and diaries associated with the study.
  5. Willing to not begin taking any new supplements while testing this product and continue taking any supplements they are currently using regularly.
  6. Completion of baseline Short Form Survey (SF-36)

Exclusion Criteria:

  1. Women who are pregnant, breastfeeding or planning to become pregnant during the trial
  2. Known food intolerances/allergy to any ingredients in the product
  3. Having any of the following conditions: Psychiatric conditions, neurologic disorders, high blood pressure, heart conditions, endocrine disorders, cancer
  4. Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
  5. On immunosuppressive therapy


This beta test has been completed